Menstrual Blood Test Detects HPV as Well as Standard Exam

A simple cotton strip might soon replace the dreaded speculum for cervical cancer screening, offering hope to millions who skip this life-saving test.

Researchers in China studied over 3,000 women and found that testing menstrual blood for HPV detected the cancer-causing virus with 94.7 percent accuracy. That's even better than the standard pelvic exam method, which correctly identified HPV 92.1 percent of the time.

The process couldn't be simpler. Women place a cotton strip on their sanitary pad during menstruation, then send it to a lab for testing. No uncomfortable medical devices, no clinic visits required.

This matters because nearly one in four Americans who should get screened for cervical cancer aren't up to date. HPV causes almost all cervical cancer cases, making regular screening critical for catching problems early.

Many people avoid these exams for valid reasons. Some have experienced trauma or sexual violence. Others face cultural barriers, physical disabilities, or simply find the traditional method too uncomfortable, especially after menopause.

The Chinese study, published in BMJ, included women from both rural and urban areas with diverse educational backgrounds. Each woman provided both a menstrual blood sample and a traditional cervical sample for comparison.

Why This Inspires

This research opens doors for people who've been left behind by traditional screening methods. Women in remote areas without easy access to gynecologists could screen themselves at home. Survivors of sexual assault wouldn't need to endure potentially triggering exams. People with disabilities could avoid difficult positioning required for pelvic exams.

The U.S. already took a step forward in January by approving at-home HPV collection using tampon-like devices. Insurance companies must cover these tests starting in 2027. The menstrual blood method could make screening even more accessible since it doesn't require insertion of any device.

Some experts urge caution, noting the method only works for women who menstruate regularly and uses a device not yet commercially available. Dr. Marta del Pino from Hospital Clínic of Barcelona emphasizes that more research in diverse settings is needed before widespread adoption.

Still, the study authors believe menstrual blood testing could integrate into national screening guidelines, making large-scale prevention programs more feasible and acceptable to women worldwide.

Saving lives from cervical cancer shouldn't require anyone to choose between their comfort and their health.